AZD6244

selumetinib · AstraZeneca

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for AZD6244, covering 2014-08-13 to 2024-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Docetaxel With or Without AZD6244 in Melanoma [Phase 2]